Charles River Laboratories | CRL - Operating Expenses


Charles River Laboratories reported $918.41M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.42B 57M Sep/2025
Align Technology USD 822.85M 11.8M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 900.9M 124.3M Dec/2025
Cardinal Health USD -2.88B 5M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Cigna USD 41.8B 23.4B Sep/2025
Concord Medical Services Hldg CNY 498.54M 170.26M Jun/2023
CVS Health USD 103.58B 3.66B Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 1.48B 653M Sep/2025
Elevance Health USD 49.17B 5.21B Dec/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Humana USD 33.32B 1.07B Dec/2025
Illumina USD 903M 69M Dec/2025
Incyte USD 1.12B 3.53B Dec/2025
Intrexon USD 61.56M 26.1M Jun/2024
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Lonza CHF 3.09B 564M Dec/2024
McKesson USD 104.5B 2.85B Dec/2025
Merck EUR 4.11B 117M Sep/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
United Therapeutics USD 6.59B 6.07B Sep/2025
UnitedHealth USD 109.96B 1.11B Dec/2025
Veradigm USD 126.92M 29.33M Sep/2022
Waters USD 661.85M 1.67B Dec/2025
West Pharmaceutical Services USD 642.5M 2.41B Dec/2025